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Background. Antibiotic use prior to seeking care at a hospital may reduce the sensitivity of blood culture for enteric fever, with 
implications for both clinical care and surveillance. The Surveillance for Enteric Fever in Asia Project (SEAP) is a prospective study 
of enteric fever incidence in Nepal, Bangladesh, and Pakistan. Nested within SEAP, we evaluated the accuracy of self-reported anti-
biotic use and investigated the association between antibiotic use and blood culture positivity.
Methods. Between November 2016 and April 2019, we collected urine samples among a subset of SEAP participants to test for 
antibiotic use prior to the hospital visit using an antibacterial activity assay. All participants were asked about recent antibiotic use 
and had a blood culture performed. We used mixed-effect logit models to evaluate the effect of antimicrobial use on blood culture 
positivity, adjusted for markers of disease severity.
Results. We enrolled 2939 patients with suspected enteric fever. Antibiotics were detected in 39% (1145/2939) of urine samples. 
The correlation between measured and reported antibiotic use was modest (κ = 0.72). After adjusting for disease severity, patients 
with antibiotics in their urine were slightly more likely to be blood culture positive for enteric fever; however, the effect was not sta-
tistically significant (prevalence ratio, 1.22 [95% confidence interval, .99–1.50]).
Conclusions. The reliability of self-reported prior antibiotic use was modest among individuals presenting with fever to tertiary 
hospitals. While antibiotics are likely to reduce the sensitivity of blood culture, our findings indicate that there is still considerable 
value in performing blood culture for individuals reporting antibiotic use.
Keywords.  enteric fever; typhoid; antimicrobial resistance; blood culture.
Enteric fever, caused by Salmonella enterica subspecies enterica 
serotypes Typhi and Paratyphi A, is a major cause of morbidity 
in South Asia [1]. Antibiotic treatment is one of the mainstays 
of enteric fever management and is responsible for a marked 
reduction in mortality from a disease that had a case fatality 
rate of 10%–25% in the pre–antibiotic era [2]. Unfortunately, 
accurate diagnosis of enteric fever remains a major challenge. 
Enteric fever is difficult to distinguish clinically from other 
causes of acute febrile illness [3–5], and there are no rapid di-
agnostic tests available to inform appropriate therapy with 
sufficient accuracy [6, 7]. Blood cultures have low sensitivity of 
50%–60% and take 48–72 hours to provide results, which limits 
their utility in clinical decision-making [8].
Antibiotic use prior to seeking care at a hospital may re-
duce the sensitivity of blood culture for enteric fever [8, 9], 
with implications for both clinical care and surveillance. In 
resource-constrained environments, it is sometimes ques-
tioned whether there is sufficient value in performing blood 
culture among individuals who report recent antibiotic use, 
because of the perceived impact that antibiotic use has on the 
yield of blood cultures. However, ascertaining antimicrobial 
use accurately is difficult. In contexts where antimicrobials are 
easily available, few pharmaceutical records exist, and many 
people struggle to distinguish antibiotics from other medica-
tions such as antipyretics or antidiarrheal. Relying on self- or 
caregiver-reported antibiotic use can be misleading [10–13]. 
Urine antibacterial assays quantify antibiotic presence in the 
urine and are an appealing alternative to reported antibiotic 
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available and antibiotic knowledge and awareness are known 
to be low.
Easy access and indiscriminate use of antibiotics prior to 
formal care may be an important contributor to the emerging 
threat of antimicrobial resistance. Rising rates of antimicro-
bial resistance may undermine treatment effectiveness for en-
teric fever as well as other infectious diseases [15]. Critically, 
the empiric use of antibiotics in patients with nonspecific fe-
brile illnesses, suspected of having enteric fever, may have im-
plications for antibacterial resistance beyond that of typhoidal 
Salmonella. Therefore, measuring patterns of antibiotic use for 
febrile illness in enteric-fever endemic settings may enhance 
our understanding of the drivers of antimicrobial resistance.
To investigate patterns of antibiotic use among patients 
with acute febrile illness, we conducted a substudy among pa-
tients presenting to outpatient departments who were enrolled 
in the Surveillance for Enteric Fever in Asia Project (SEAP) 
study sites in Bangladesh, Nepal, and Pakistan. Our objectives 
were to characterize prehospital antibiotic use among patients 
with suspected enteric fever in South Asia according to dem-
ographic and clinical characteristics, evaluate the accuracy of 
self-reported antibiotic use, and investigate the relationship be-
tween antibiotic use and culture positivity.
MATERIALS AND METHODS
Overall Design
This study was nested within the SEAP study, a longitudinal 
surveillance study for typhoid and paratyphoid fevers in 
Bangladesh, Nepal, and Pakistan. SEAP study methods are pre-
sented elsewhere [16, 17]. Individuals presenting to outpatient 
departments with 3 or more consecutive days of fever in the 
prior 7 days were eligible to enroll in SEAP. We collected urine 
samples from a subset of this population to test for the presence 
of antimicrobial activity and inquired about their antibiotic use.
Study Population
SEAP patients presenting to the outpatient department at any 
of the 6 study hospitals with 3 or more consecutive days of fever 
were eligible to participate. Participants were enrolled con-
secutively from September 2016 through April 2019 until the 
target sample size was reached. All study hospitals were tertiary 
facilities: 2 in Dhaka, Bangladesh; 1 in Kathmandu, Nepal; 1 
in Kavrepalanchok, Nepal; and 2 in Karachi, Pakistan. While 
participants of any age were eligible to participate, the hospital 
study sites in Bangladesh serve primarily pediatric populations.
Measurements and Definitions
The eligibility criteria of 3 or more consecutive days of fever 
in the previous 7 days was assessed by self-report or caregiver 
report. We interviewed all study participants, using a standard-
ized questionnaire to ascertain demographic and clinical his-
tory. A sample of peripheral venous blood was collected from 
each participant, inoculated into a BACTEC Aerobic bottle or 
PED Plus bottle, and incubated in a BACTEC system for 5 days. 
One blood culture was performed per patient. Samples that in-
dicated positivity in the BACTEC system were subcultured onto 
MacConkey agar plates and nonselective media (sheep blood 
agar). We identified the species with biochemical testing and 
confirmed serologically, using O and H antisera (BD labora-
tories), when available.
We also requested a sample of at least 3 mL of urine in a sterile 
collection cup from the participants before any antibiotics were pre-
scribed or administered at the study facility. Urine was collected the 
same day blood was drawn for culture. These samples were either 
processed immediately or stored at 2°C–8°C and processed the fol-
lowing day or stored at −80°C and processed within a month. In an 
internal validation study of 10 samples, there was no difference in 
susceptibility between fresh samples and samples stored at −20°C 
and −80°C for up to 3 months’ storage time.
To test for the presence of antibiotics, we prepared a bacte-
rial lawn of Kocuria rhizophila (previously Micrococcus luteus) 
(ATCC:9341) on Mueller-Hinton agar (Oxoid: CM033) with 5% 
sheep’s blood. Kocuria rhizophila has been previously used to 
detect low concentrations of antibiotics in biological fluids be-
cause of its high susceptibility to antibiotics [18, 19]. We placed 
a type of sterile blank disk (Oxoid: CT998) used in Kirby-Bauer 
disk diffusion testing on the lawn of bacteria and added 8–10 µL 
of the urine sample to the disk. After incubating the plate for 24 
hours at 37°C, we measured the zone of inhibition around the 
disk. Any zone of inhibition around the disk was interpreted as 
detection of antibiotics in the urine. We did quality control of 
the media during the preparation of each batch, by testing the 
positive and negative control disks on the bacterial lawn.
We inquired about care-seeking and antibiotic use in the 
7 days prior to presenting for care at the study facility by asking 
the following questions to all participants: “For this febrile ill-
ness, before arriving for this visit, did you/the participant seek 
any type of medical advice or treatment for your/their symp-
toms, such as a health clinic, other hospital, pharmacy, or pri-
vate healthcare provider?” and “Before arriving for this visit, did 
you/the participant take any of the following medications, such 
as antibiotics, antipyretics, analgesics, and antidiarrheals?”
We did not collect additional information on the specific anti-
biotics consumed. We also collected information about house-
hold assets, education  and self-reported clinical symptoms. If 
the participants were <15 years old, we asked these questions to 
their caregiver or guardian.
Statistical Analysis
The primary outcome was the presence of antibiotics in the 
urine as measured by the biological assay described above. We 
reported the proportion of participants with antibiotics de-
tected in their urine samples, along with 95% confidence inter-
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component analysis to construct a wealth index variable from 
the household asset data for these analyses. We used binomial 
mixed-effect logit models for all the remaining analyses with 
random effects for hospital site and country to account for clus-
tering. We report the results as prevalence ratios, calculated 
from the probability-logit transformations from the mixed 
models [20]. We calculated the sensitivity and specificity of re-
ported antibiotic use with antibiotics detected in the urine as 
the reference standard.
We evaluated the relationship between antibiotics detected in 
the urine and blood culture positivity for S. Typhi/S. Paratyphi. We 
ran an unadjusted model (model 1) alongside a model adjusted for 
markers of disease severity (days unable to complete normal activity 
and hours spent in bed on the worst day of illness), days of fever, 
and age, which we hypothesized might confound the association 
between the antibiotic use and culture positivity.
We anticipated that 30% of the study patients would have 
antibiotics detected in their urine. To estimate prevalence across 
the 3 age groups with a width of the 95% CI of ±5% required 969 
participants per site.
We used R version 3.6.0 software for all our analyses.
Ethics Statement
All participants gave informed consent; in the case of minors, 
verbal assent and informed consent were provided by a parent 
or guardian. The study was approved by the Nepal Health 
Research Council, Bangladesh Institute of Child Health Ethical 
Review Committee, Pakistan Ethical Review Committee, 
the US Centers for Disease Control and Prevention, and the 
Institutional Review Board at Stanford University.
RESULTS
We recruited 2939 individuals presenting to the outpatient de-
partment at SEAP study hospitals with a fever of 3 or more days 
in the past week. This included 999 participants in Bangladesh, 
1001 in Nepal, and 939 in Pakistan. The median age of the par-
ticipants was 10 years (interquartile range [IQR], 5–25 years), 
and 1246 (42.4%) of the participants were female. The median 
temperature at hospital presentation was 37.2 C (IQR, 36.7–
38.2), and patients reported a median of 4 days (IQR, 3–6 days) 
of fever (Table 1). All participants had a blood culture, and 373 
(12.7%) tested positive for S. Typhi or S. Paratyphi. Culture pos-
itivity was higher in Bangladesh (20.1%) and Pakistan (14.5%) 
and lower in Nepal (3.6%).
Overall, we detected antibiotics in the urine samples of 1145 
(39%) participants: 377 (37.7%) in Bangladesh, 264 (26.4%) in 
Nepal, and 504 (53.8%) in Pakistan. In contrast, 1259 (43.7%) 
participants reported taking antibiotics prior to seeking care: 
412 (42.4%) in Bangladesh, 417 (42.4%) in Nepal, and 430 
(46.2%) in Pakistan (Table  1). In Bangladesh and Nepal, re-
ported antibiotic use was higher than the detected antibiotics 
across all age groups (Figure 1).
When asked about care-seeking for the current illness prior 
to presentation at the study hospital, the most common loca-
tion reported was a pharmacy, followed by a hospital or clinic. 
However, there were substantial differences between countries. 
For example, only 2.4% of the participants sought care at a 
pharmacy in Pakistan compared with 56.7% in Bangladesh and 
59.6% in Nepal (Table 1). In Nepal, the percentage of children 
taken to the hospital decreased with age, while the percentage 
of patients visiting a pharmacy increased with age (Figure 2). 
However, this finding was not observed in other sites.
Table 1. Characteristics of Enrolled Patients With Enteric Fever by 
Country, Surveillance for Enteric Fever in Asia Project—Bangladesh, 




Nepal   
(n = 1001)
Pakistan   
(n = 939)
Total   
(N = 2939)
Female sex 423 (42.3) 413 (41.3) 410 (43.7) 1246 (42.4)
Age, y
 <2 77 (7.7) 19 (1.9) 32 (3.4) 128 (4.4)
 2–4 370 (37.0) 105 (10.5) 102 (10.9) 577 (19.6)
 5–15 552 (55.3) 232 (23.2) 310 (33.0) 1094 (37.2)
 16–25 0 (0.0) 248 (24.8) 138 (14.7) 386 (13.1)
 >25 0 (0.0) 397 (39.7) 357 (38.0) 754 (25.7)
Temperature at hospital presentation, °C
 Median 37.3 37.2 37.5 37.2
 IQR 36.6–38 36.6–38.1 36.7–38.3 36.7–38.2
Days of fever before hospital presentation
 Median 4.0 4.0 5.0 4.0
 IQR 3.0–6.0 3.0–5.0 3.0–6.0 3.0–6.0
Days unable to complete normal activity
 Median 2.0 3.0 3.0 3.0
 IQR 0.0–4.0 2.0–5.0 2.0–5.0 1.0–5.0
Reported diarrhea 62 (6.2) 109 (10.9) 163 (17.4) 334 (11.4)
Diagnosed with enteric 
fever
816 (81.7) 198 (19.8) 466 (49.7) 1480 (50.4)
Blood culture positive for 
S. Typhi or S. Paratyphi
201 (20.1) 36 (3.6) 136 (14.5) 373 (12.7)
Antibiotics detected in 
urine
377 (37.7) 264 (26.4) 504 (53.8) 1145 (39.0)
Antibiotic use reported 412 (42.4) 417 (42.4) 430 (46.2) 1259 (43.7)
Prior care-seeking     
 Hospital 97 (21.5) 171 (22.1) 340 (47.2) 608 (31.3)
 Pharmacy 247 (56.7) 461 (59.6) 17 (2.4) 725 (37.7)
 Clinic 3 (0.7) 144 (18.6) 239 (33.9) 386 (20.0)
 Physician 78 (17.3) 5 (0.6) 210 (29.5) 293 (15.1)
 Traditional healer 11 (2.4) 1 (0.1) 3 (0.4) 15 (0.8)
Wealth index quintile
 1 (lowest) 79 (18.0) 22 (5.2) 173 (34.5) 274 (20.1)
 2 68 (15.5) 74 (17.4) 131 (26.1) 273 (20.0)
 3 67 (15.3) 91 (21.4) 115 (22.9) 273 (20.0)
 4 87 (19.8) 104 (24.5) 82 (16.3) 273 (20.0)
 5 (highest) 138 (31.4) 134 (31.5) 1 (0.2) 273 (20.0)
Highest education, female head of household
 None 23 (5.2) 158 (39.7) 144 (27.6) 325 (23.8)
 Primary 204 (45.8) 80 (20.1) 96 (18.4) 380 (27.9)
 Secondary 130 (29.2) 93 (23.4) 133 (25.5) 356 (26.1)
 Postsecondary 88 (19.8) 67 (16.8) 148 (28.4) 303 (22.2)
Data are presented as no. (%) unless otherwise indicated.
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Antibiotic detection in urine was positively associated with 
having ≥7 days of fever (prevalence ratio [PR], 1.32 [95% CI, 
1.19–1.45]), temperature of 38.3 C at presentation (PR, 1.19 
[95% CI, 1.06–1.32]), having ≥3 days of being unable to conduct 
normal activities (PR, 1.14 [95% CI, 1.03–1.26]), and having di-
arrhea (PR, 1.19 [95% CI, 1.03–1.35]) (Table 2). Seeking care 
at a hospital, clinic, or pharmacy or with a physician for the 
current illness prior to presenting to the study hospital was also 
associated with a higher probability of detecting antibiotics in 
the urine samples (Table 2). There was no apparent association 
between wealth or education and antibiotics being detected in 
the urine (Table  2). These associations were consistent at the 
Figure 2. Age and facility care-seeking for current illness by country, Surveillance for Enteric Fever in Asia Project—Bangladesh, Nepal, and Pakistan, 2016–2019. 
Percentage of patients seeking care at a clinic, hospital, pharmacy, physician, or traditional healer prior to presenting to the study site among 2939 outpatients with ≥3 con-
secutive days of fever in Bangladesh, Nepal, and Pakistan.
Figure 1. Differences between antibiotic detection and report across study country and age strata, Surveillance for Enteric Fever in Asia Project—Bangladesh, Nepal, 
and Pakistan, 2016–2019. Differences in the percentage of patients reporting antibiotic use and patients with antibiotics detected in the urine by country and age category 
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country level as well, barring the association between diarrhea 
and antibiotic detection in Bangladesh and seeking care at a 
pharmacy and antibiotic detection in Nepal (Table 3).
Individuals who had antibiotics detected in their urine 
were more likely to be blood culture positive for S. Typhi or S. 
Paratyphi A compared with individuals who had no antibiotics 
in their urine (PR, 1.33 [95% CI, 1.10–1.60]). When adjusting 
for the duration of fever, days in bed, diarrhea, age, and wealth, 
the prevalence ratio decreased to 1.22 (95% CI, .99–1.50) and 
was no longer statistically significant (P = .065) (Table  4). 
When restricting to patients with a clinical diagnosis of enteric 
fever, individuals with antibiotics in their urine were still more 
likely to be blood culture positive for S. Typhi or S. Paratyphi 
compared with those who had no antibiotics detected in their 
urine in the unadjusted analysis (PR, 1.29 [95% CI, 1.05–1.55]; 
P = .014).
The sensitivity and specificity of reported antibiotic use com-
pared to the detection of antibiotics in the urine were 70.2% (95% 
CI, 57.9%–80.2%) and 72.6% (95% CI, 66.1%–79.1%), respec-
tively. Correlation between measured and reported antibiotic 
use was modest in all 3 countries but was higher in Bangladesh 
(κ = 0.74) and Nepal (κ = 0.73) than in Pakistan (κ = 0.62). The 
sensitivity of reported antibiotic use was slightly higher for parents 
and guardians compared to self-report (Table 5).
DISCUSSION
Antibiotic use prior to presentation to hospitals may have im-
portant implications for diagnostic evaluation by clinicians 
and for pathogen surveillance systems. However, the reli-
ability of self-report of recent antibiotic use is unclear, and 
whether individuals who report prior antibiotic use should 
be included in blood culture–based surveillance systems has 
been debated. To address these knowledge gaps, we evaluated 
Table 2. Antibiotic Detection in Urine by Demographic and Behavioral 
Factors, Surveillance for Enteric Fever in Asia Project—Bangladesh, 
Nepal, and Pakistan, 2016–2018
Characteristic
Antibiotics  
Detected (n = 1145), 
No. (%)
Total 







 <2 55 (43.0) 128 Ref  
 2–4 223 (38.8) 575 0.91 
(.70–1.14)
.429
 5–15 394 (36.0) 1093 0.83 
(.64–1.05)
.122
 16–25 134 (34.7) 386 0.96 
(.72–1.22)
.753
 >25 339 (45.0) 754 1.11 (.88–1.35) .363
Sex
 Male 652 (38.6) 1691 Ref  
 Female 493 (39.6) 1245 1.02 
(.92–1.12)
.694
Fever duration ≥7 d
 No 859 (36.5) 2356 Ref  
 Yes 279 (50.0) 558 1.32 (1.19–
1.45)
<.001
Temperature at presentation 38.3 C
 No 817 (39.6) 2064 Ref  
 Yes 236 (45.0) 524 1.19 (1.06–
1.32)
.004
≥3 d unable to conduct activity
 No 399 (35.7) 1118 Ref  




 No 983 (37.8) 2600 Ref  
 Yes 162 (48.5) 334 1.19 (1.03–
1.35)
.018
Prior to enrollment, patient sought care at a hospital
 No 786 (34.1) 2302 Ref  
 Yes 340 (56.1) 606 1.54 (1.40–
1.69)
<.001
Prior to enrollment, patient sought care at a pharmacya
 No 862 (39.9) 2160 Ref  
 Yes 246 (33.9) 725 1.20 (1.07–
1.33)
.003
Prior to enrollment, patient sought care at a clinic
 No 922 (36.8) 2508 Ref  
 Yes 201 (52.2) 385 1.31 (1.15–
1.47)
<.001
Prior to enrollment, patient sought care with a physician
 No 950 (36.4) 2608 Ref  
 Yes 171 (58.6) 292 1.43 (1.24–
1.62)
<.001
Prior to enrollment, patient sought care with a traditional healer
 No 1119 (38.7) 2893 Ref  




 1 (lowest) 125 (45.8) 273 Ref  
 2 126 (46.2) 273 1.10 
(.90–1.30)
.333
 3 101 (37.1) 272 0.92 
(.71–1.15)
.511





Detected (n = 1145), 
No. (%)
Total 






 5 (highest) 86 (31.5) 273 1.03 
(.80–1.26)
.803
Female head of household, highest education attained
 None 123 (38.0) 324 Ref  
 Primary 161 (42.5) 379 1.14 
(.92–1.36)
.224
 Secondary 134 (37.6) 356 0.95 
(.75–1.17)
.648
 Postsecondary 128 (42.2) 303 1.02 
(.80–1.26)
.848
PRs are estimates using mixed-effect models with random effects for country and site 
hospital and are adjusted for age.
Abbreviations: CI, confidence interval; PR, prevalence ratio.
aBecause of heterogeneity in care seeking and antibiotic use by country, antibiotic use 
among individuals who sought care at a pharmacy appears lower than those who did not 
seek care at a pharmacy; however, when accounting for differences by country in the 
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antibiotic use, self-report, and blood culture positivity among 
a subset of outpatients presenting to hospitals in Bangladesh, 
Nepal, and Pakistan. Antibiotic use across all 3 countries was 
high, with 1 of every 3 participants having antibiotic activity 
confirmed in their urine assay upon presenting at the tertiary 
care study site. Patients presenting with more severe disease 
(higher temperature at presentation, more days of fever, diar-
rhea, and longer time unable to complete normal activities) 
were more likely to have taken antibiotics than those with 
less severe disease. Many patients had sought care at other 
facilities prior to presenting at the study-site facility; of these, 
those who sought care at other hospitals or with physicians 




PR (95% CI) P Value PR (95% CI) P Value PR (95% CI) P Value
Age, y
 <2 Ref  Ref  Ref  
 2–4 0.88 (.64–1.16) .398 1.12 (.34–2.84) .842 0.95 (.59–1.31) .795
 5–15 0.75 (.53–1.01) .061 1.41 (.47–3.20) .518 0.89 (.57–1.22) .527
 16–25 …  1.47 (.49–3.28) .463 1.02 (.67–1.36) .900
 >25 …  1.83 (.65–3.72) .230 1.13 (.80–1.43) .434
Female sex 1.16 (.98–1.34) .078 0.92 (.73–1.13) .421 0.98 (.86–1.09) .711
Fever duration ≥7 da 1.52 (1.29–1.75) <.001 1.17 (.88–1.50) .262 1.22 (1.06–1.36) .006
Temperature at presentation >38.3 Ca 1.34 (1.11–1.57) .004 1.39 (1.04–1.78) .027 1.02 (.87–1.16) .810
≥3 d unable to conduct activitya 1.13 (.95–1.32) .172 1.24 (.98–1.54) .067 1.15 (1.01–1.29) .042
Diarrheaa 0.92 (.63–1.26) .631 1.19 (.86–1.58) .275 1.25 (1.09–1.40) .003
Prior care-seeking for current illnessa
 Hospital 1.65 (1.34–1.94) <.001 2.03 (1.65–2.42) <.001 1.25 (1.11–1.37) <.001
 Pharmacy 1.64 (1.39–1.88) <.001 0.89 (.70–1.11) .292 1.05 (.61–1.44) .843
 Clinic 2.11 (.65–2.63) .146 1.45 (1.11–1.83) .007 1.19 (1.05–1.32) .008
 Physician 2.11 (1.77–2.39) <.001 1.29 (.29–2.90) .698 1.06 (.91–1.20) .454
 Traditional healer 1.36 (.63–2.08) .377 0.00 (.00–3.81) .911 0.57 (.06–1.56) .441
Wealth index quintile
 1 (lowest) Ref  Ref  Ref  
 2 0.93 (.59–1.34) .744 1.19 (.52–2.13) .647 1.15 (.92–1.36) .199
 3 0.75 (.44–1.15) .210 0.81 (.33–1.66) .616 1.05 (.82–1.27) .683
 4 1.04 (.68–1.43) .849 0.71 (.28–1.49) .400 1.23 (.97–1.46) .083
 5 (highest) 0.99 (.67–1.34) .940 0.88 (.37–1.70) .731 – –
Female head of household, highest education attained
 None Ref  Ref  Ref  
 Primary 1.07 (.61–1.55) .796 0.68 (.39–1.12) .139 1.23 (.96–1.47) .092
 Secondary 0.76 (.38–1.27) .351 0.73 (.44–1.15) .192 1.17 (.92–1.40) .177
 Postsecondary 0.87 (.44–1.41) .638 0.80 (.46–1.30) .395 1.19 (.95–1.41) .117
Abbreviations: CI, confidence interval; NaN, xxx; PR, prevalence ratio.
aAdjusted for age.
Table 4. Antibiotic Detection in the Urine and Blood Culture Positivity, Surveillance for Enteric Fever in Asia Project—Bangladesh, Nepal, and Pakistan, 
2016–2019
Detection
Model 1 (Unadjusted) Model 2a Model 3b
PR (95% CI) P Value PR (95% CI) P Value PR (95% CI) P Value
Overall 1.33 (1.1–1.6) .004 1.22 (.99–1.5) .065 1.29 (1.05–1.55) .014
Country
 Bangladesh 1.34 (1.05–1.67) .019 1.25 (.96–1.6) .102 1.28 (1.01–1.6) .041
 Nepal 1.77 (.92–3.3) .088 1.38 (.52–3.54) .518 0.69 (.19–2.27) .557
 Pakistan 1.19 (.87–1.59) .277 1.26 (.9–1.71) .171 1.38 (.97–1.89) .074
Abbreviations: CI, confidence interval; PR, prevalence ratio.
aModel 2: Adjusted for fever duration, days unable to complete normal activity, temperature at presentation, age, wealth.
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were more likely to have taken antibiotics. In contrast to what 
is often presumed, patients who had taken antibiotics prior 
to presentation were more likely to be culture positive than 
those who did not have evidence of antibiotics in their urine. 
Finally, the accuracy of self-reported or caregiver-reported 
antibiotic use compared to antibiotics detected in the urine 
was modest in all 3 countries.
The impact of antimicrobial use on the sensitivity of blood 
culture of S. Typhi and S. Paratyphi is not well characterized 
[21]. A  recent meta-analysis found that reported prior anti-
biotic use was associated with a 34% decreased sensitivity of 
blood culture, although the size of the studies was small and 
there was substantial heterogeneity between them. Additionally, 
all studies were performed between the 1970s and 1990s, when 
different antibiotics were used for treatment of suspected en-
teric fever than those commonly used today. To investigate the 
impact of currently used antibiotics (eg, azithromycin, cefixime, 
and ceftriaxone) on culture sensitivity, a reference standard not 
strongly affected by antibiotics is needed. Historically, studies 
have used bone marrow cultures, which are less rapidly affected 
by antibiotics due to higher bacterial concentrations; however, 
this procedure is invasive, painful, and not widely performed 
today. Newer serologic diagnostics have demonstrated promise 
for improving the diagnosis of typhoid and may be useful as 
non-culture-based references for future studies [22, 23].
While we found higher culture positivity among individuals 
with prior antibiotic use, we believe that this was due to con-
founding whereby individuals who continued to have fever de-
spite continued antibiotic use are more likely to have typhoid 
than other illnesses. The duration of fever in typhoid is charac-
teristically longer than the other common causes of fever. Even 
after antibiotic use, the average fever clearance time in clinical 
trials for enteric fever treatment is around 5 days [24]. Persistent 
fever despite antibiotic use may therefore be a marker of enteric 
fever. This may be particularly true if individuals received anti-
biotics to which their S. Typhi or S. Paratyphi A isolate was not 
susceptible. Because antimicrobial resistance was widespread 
and fairly homogeneous within study sites, and the assay we 
used could not distinguish between specific antibiotics, we were 
unable to assess whether antimicrobial resistance mediated the 
effects of prior antibiotic use on culture positivity.
While self- or caregiver-reported antibiotic use is widely 
thought to be inaccurate, few studies have documented the 
validity of reported antibiotic use against a urine antibacterial 
assay in the South Asia region [10–13]. Our results were com-
parable to a study of young children with respiratory tract in-
fections in the Philippines, where the sensitivity and specificity 
of caregiver-reported antibiotic use were 59% and 71%, respec-
tively [25]. The low sensitivity documented in our study indi-
cates that both clinicians and researchers should use caution 
when interpreting self- and caregiver-reported antibiotic use.
The results of this study should be interpreted within the 
context of the limitations of the design and study procedures. 
Biologic assays for antibiotic metabolites in urine may have lim-
ited sensitivity, which could lead to underestimation of prior 
antibiotic use and bias associations between demographic and 
clinical features, likely toward the null [26]. Their accuracy 
likely varies by antibiotic class, the number of doses taken, and 
Table 5. Sensitivity and Specificity of Antibiotic Use Reporting by Country and Caregiver Type, Surveillance for Enteric Fever in Asia Project—Bangladesh, 
Nepal, and Pakistan, 2016–2019
Variable TPa FNb TNc FPd Sensitivity, % (95% CI) Specificity, % (95% CI)
Overall 781 342 1280 478 70.2 (57.9–80.2) 72.6 (66.1–79.1)
Country
 Bangladesh 288 74 485 124 75.2 (59.2–86.4) 80.5 (74.2–86.7)
 Nepal 204 56 509 213 78.9 (64.5–88.5) 69.2 (61.3–77.0)
 Pakistan 289 212 286 141 56.6 (40.0–71.8) 67.1 (58.5–75.6)
Respondent typee
 Self 279 152 435 161 67.4 (51.9–79.8) 69.5 (59.5–79.5)
 Parent or guardian 454 166 770 279 72.3 (58.6–82.8) 74.8 (67.0–82.7)
 Other relative 47 24 71 38 70.3 (52.0–83.7) 68.6 (56.7–80.5)
Age, y
 <2 35 20 42 31 62.3 (42.0–79.0) 51.8 (36.3–67.2)
 2–4 161 56 248 100 74.9 (60.8–85.2) 67.7 (57.5–77.8)
 5–15 284 101 507 174 75.8 (62.9–85.2) 72.4 (63.8–80.9)
 16–25 85 46 187 63 65.6 (49.0–79.0) 77.8 (69.2–86.5)
 >25 216 119 296 110 62.7 (47.5–75.8) 77.7 (69.7–85.7)
Abbreviations: CI, confidence interval; FN, false negative; FP, false positive; TN, true negative; TP, true positive.
aTrue positive: Number of patients who reported antibiotic use and had antibiotics detected in their urine.
bFalse negative: Number of patients who did not report antibiotic use who did have antibiotics detected in their urine.
cTrue negative: Number of patients not reporting antibiotic use who did not have antibiotics detected in their urine.
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recentness of the last dose. We did not have data about timing 
of doses or concentrations of antibiotics or their metabolites in 
urine over time. The assay used in our study did not enable us 
to distinguish between different antibiotic classes. It is possible 
that nonantibiotic metabolites in the urine or other chemical 
properties (eg, pH, urea, and ammonia concentrations) could 
have inhibited Kocuria growth, leading to false-positive results 
[27–29]. Although we did not observe bacterial inhibition in 
urine collected from healthy controls individuals during a pilot 
phase, it is possible that these chemical properties are altered in 
individuals with acute illness.
Despite these limitations, this is the largest study to date 
evaluating prior antibiotic use among enteric fever suspects 
and the associations with culture positivity and self-reported 
use. We unexpectedly found that individuals with reported 
antibiotic use were more likely to be culture positive for en-
teric fever; however, this relationship was confounded by di-
sease severity. While antibiotics may reduce the sensitivity of 
blood culture, our findings indicate that there is still consid-
erable value in performing blood culture among individuals 
reporting antibiotic use. Given the continuing emergence 
and spread of antimicrobial resistance among typhoidal 
Salmonella [15, 30], a better understanding of the relationship 
between antibiotic usage patterns and typhoid detection and 
resistance may improve our ability to monitor and respond to 
this epidemic.
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